PhD Position – Targeted Therapy: Applications are invited for a PhD position in the field of targeted radionuclide therapy, focusing on the development and implementation of protein-based chelators. This project aims to enhance the production of radiopharmaceuticals using innovative protein-based alternatives fused directly to proteinous carriers. The goal is to capture large radioisotopes with high specificity and stability under mild conditions, preserving the carrier protein’s binding capacity. This is a unique opportunity to contribute to the advancement of cancer treatment through targeted radionuclide therapy.
PhD Position – Protein-based Chelators for Targeted Radionuclide Therapy
Designation: PhD Candidate
Research Area: Protein-based Chelators for Targeted Radionuclide Therapy
Location: RadioPharma Research, SCK CEN, Belgium
Eligibility/Qualification:
- Minimum diploma level: Master of Sciences
- Background in Biology, (Bio)chemistry, or Bio-engineering
- Duration: 4 years
Job Description:
- Develop and implement protein-based alternatives to synthetic chemical chelators for targeted radionuclide therapy.
- Benchmark and evaluate the performance of protein-based chelators directly fused to proteinous carriers (e.g., peptides or nanobodies).
- Contribute to the advancement of radiopharmaceuticals with a focus on capturing large radioisotopes with high specificity and stability.
How to Apply:
- Visit the application link to apply for the PhD position.
- Before applying, carefully review the guidelines for the application provided on the official website.
- For inquiries about the position, contact the SCK CEN Mentor, Rob Van Houdt, at rob.van.houdt@sckcen.be or +32 (0)14 33 27 28.
- Contact the SCK CEN Co-mentor, Kristel Mijnendonckx, at kristel.mijnendonckx@sckcen.be or +32 (0)14 33 21 06.
- For further details, contact the Promoter, Joleen Masschelein, at joleen.masschelein@kuleuven.be, Katholieke Universiteit Leuven (KU Leuven).
Last Date for Apply: Applications accepted as of March 5th, 2024. Ensure timely submission.